Trials / Completed
CompletedNCT06335108
Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )
Prospective Unicentre Non-randomised Study: Comparison of Postoperative Pain After Breast Cancer-typical Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia - TLA 001
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 349 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present study aims to investigate the impact of Tumescent Local Anesthesia (TLA) on pain perception following surgeries typical for breast cancer. Previous research has already confirmed the feasibility of conducting operations in TLA for benign breast conditions. In contrast to general anesthesia, Tumescent Local Anesthesia involves local anesthesia of the surgical site, allowing patients to remain awake during the procedure and eliminating the risks associated with general anesthesia. Additionally, if needed, sedatives or further anesthesia can be administered through the vein. Building upon the successful applications of TLA in benign breast surgeries, this follow-up study at the Department of Women's Health focuses on enhancing surgical techniques, pain management, and postoperative care for breast cancer-related procedures. Simultaneously, our goal is to gather scientific data regarding the application of this technique. This research contributes to the continuous advancement of medical practices in the field of breast surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | General Anaesthesia | Breast surgery is carried out under general anesthesia. |
| PROCEDURE | Local tumescent anaesthesia | Breast surgery is carried out under local tumescent anesthesia. |
Timeline
- Start date
- 2022-12-05
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2024-03-28
- Last updated
- 2026-01-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06335108. Inclusion in this directory is not an endorsement.